Launch of antiplatelet drug Inhipla Tablet

 

 

 

KyungDong Pharm Co., Ltd. will release ‘Inhipla Tablet’, a powerful antiplatelet drug containing clopidogrel, on September 1. ‘Inhipla Tablet’ is an antiplatelet medication containing 97.875 mg of Clopidogrel bisulfate (75 mg as Clopidogrel). It has a significant platelet aggregation inhibitory effect 2 hours after oral administration of one tablet, and has the advantage of a rapid effect that reduces platelet aggregation by 40-60%.
In particular, it has a lower incidence of gastrointestinal side effects, such as peptic ulcers, indigestion, and nausea/vomiting, than aspirin, a commonly used anti-platelet agent, and has secured safety with a lower rate of hematologic side effects such as bleeding, neutropenia, and thrombocytopenia and MI compared to ticlopidine, and has superior effectiveness compared to other anti-platelet agents. When prescribed in combination with aspirin in acute coronary syndrome, the risk of cardiovascular disease is observed to be lower than when prescribed with aspirin alone, and the effect can be increased by combined treatment with aspirin.
Inhipla tablets are expected to lead the antiplatelet drug market along with Rosazole tablets containing Cilostazol, a treatment for peripheral blood flow disorders previously released by KyungDong Pharm Co., Ltd.


◎ Ingredient content: Clopidogrel bisulfate 97.875mg (75mg as Clopidogrel)

◎ Effectiveness
1. Improvement of atherosclerotic symptoms in patients with stroke, myocardial infarction, or peripheral arterial disease.
2. Improvement of atherosclerotic symptoms in patients with acute coronary syndrome.

◎ Dosage and usage
1. When administering to patients with stroke, myocardial infarction, or peripheral arterial disease: Administer 1 tablet (75 mg) once a day, regardless of food intake.
2. When administering to patients with acute coronary syndrome: 300 mg of this drug is administered as an initial dose, and thereafter, one tablet is administered once a day as a maintenance dose regardless of food intake. At this time, 75 to 325 mg of aspirin is administered together with this drug once a day.

◎ Appearance: Pink round film-coated tablet

◎ Insurance price: 1,734 won/T

※ Please refer to the attached document for other details such as precautions for use.